Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related

By Huang Huei-Jean   Neven Patrick   Drijkoningen Maria   Paridaens Robert   Wildiers Hans   Limbergen Erik   Berteloot Patrick   Amant Frederic   Christiaens Marie   Vergote Ignace  

Breast Cancer Research and Treatment, Vol. 91, Iss. 1, 2005-05 ,pp. : 81-87

Springer Publishing Company

Access to resources Recommend Favorite

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

By Robertson J.F.R.   Blamey R.W.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 861-869

Elsevier

Access to resources Recommend Favorite

Long-Term Follow-up of Gonadotrophin-Releasing Hormone Analog Treatment for Recurrent Endometrial Cancer

By Jeyarajah A.R.   Gallagher C.J.   Blake P.R.   Oram D.H.   Dowsett M.   Fisher C.   Oliver R.T.D.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 47-52

Academic Press

Access to resources Recommend Favorite

Multistep Progression from an Oestrogen-dependent Growth Towards an Autonomous Growth in Breast Carcinogenesis

By Schmitt F.C.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2049-2052

Elsevier

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite